Prior reports showed that NR4A3 downregulation is a universal phenomenon in every subtype of AML, and in the current study, we show that NR4A3 downregulation is also associated with the acute transformation of CML. This evidence concerns the gene NR4A3 and chronic myelogenous leukemia, BCR-ABL1 positive.